The Effect of Frequent Self Measurements of Blood Pressure on the Control of Hypertension
Despite knowledge regarding the importance of controlling patients' blood pressure (BP) only 30% of treated patients achieve BP goals. Our objective was to determine the effect of frequent self measurements of BP in the patients' natural environment as a mean to improve BP control. Our hypothesis was that frequent measurements of BP will reduce mean BP levels...
Brief Summary
Official Title: “The Effect of Frequent Self Measurements of Blood Pressure on the Control of Hypertension”
Despite knowledge regarding the importance of controlling patients' blood pressure (BP) only 30% of treated patients achieve BP goals. Our objective was to determine the effect of frequent self measurements of BP in the patients' natural environment as a mean to improve BP control. Our hypothesis was that frequent measurements of BP will reduce mean BP levels.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Intervention(s) in this Clinical Trial
- Device: Portable blood pressure wrist manometer
Outcome Measures for this Clinical Trial
Primary Measures
- Meam blood pressure
Secondary Measures
- Satisfaction
- Quality of life
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Signing an informed consent form
- Having a diagnosis of hypertension for more than one year according to patients'records.
- receiving at least one medication for hypertension
- A reasonable understanding of Hebrew
- An ambulatory state enabling regular visits to a primary physician in the community and self-measurement of hypertension using the electronic device
Exclusion Criteria:
- Lack of willingness to participate in the study.Known arrhythmia
- Malignant disease
- Poor understanding of Hebrew
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Sheba Medical Center Other
Overall Clinical Trial Officials and Contacts
Yasmin Maor, MD Principal Investigator Sheba Medical Center
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00459017
Study ID Number: SHEBA -02-2773-YM-CTIL
ClinicalTrials.gov Identifier: NCT00459017
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00459017
